Prepared: July 28, 2026 Upcoming Earnings: Q2 2026 (expected late July / early August 2026) Last Earnings: Q1 2026 (reported April 30, 2026)
Key Takeaway: The setup into Q2 2026 is constructive but not stretched — consensus is a manageable bar after management's deliberate conservatism in Q1, and the single biggest swing factor is whether organic revenue growth sustains near the mid-teens pace seen in Q1 or reverts toward the 7% full-year guide.
Heading into Q2 2026, LHX faces a beatable consensus bar: Street revenue estimates of ~$5.83B imply ~10% YoY growth, well below the 15% organic growth LHX delivered in Q1, and management explicitly signaled conservatism in the full-year guide when the new CFO declined to raise revenue guidance despite the outsized Q1 beat. Management's tone has been unambiguously bullish — record $40B+ backlog, a 1.4x book-to-bill in Q1, $25B of MAC program negotiations not yet in backlog, and a 2.2x international book-to-bill — all pointing to durable demand well above the guide. Estimate revisions have been modest and upward since the Q1 print, with Q2 revenue consensus rising ~$43M and operating EPS essentially flat, suggesting the Street has not yet fully priced in the Q1 momentum. The stock has underperformed ITA by roughly 13 percentage points since the Q1 earnings date (LHX ~−5% vs. ITA ~+12%), driven by the muted reaction to the Q1 beat, the June 16 AXYV IPO bank selection news (which triggered a ~6% single-day decline), and broader sector rotation — creating a setup where the stock is not pricing in a beat. The key wildcard is the AXYV (Missile Solutions) IPO timeline and MAC contract definitization: any update on IPO pricing, the $25B MAC framework moving to contract, or the HBTSS follow-on award could be the catalyst that closes the gap with peers.
Key Takeaway: Consensus is a low bar on revenue (~$5.83B, implying ~10% YoY growth vs. 15% organic in Q1) and a manageable bar on operating EPS (~$2.85). Organic revenue growth rate is the bigger swing factor — any print above ~12% would likely be read as a beat; book-to-bill is the secondary signal for backlog durability.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY 2026 Guidance | Consensus vs. Guidance (% delta) |
Revenue ($B) | $5.744B | $5.426B | $5.825B | +7.4% YoY | $23.0B–$23.5B | ~−0.6% vs. midpoint |
Organic Revenue Growth (%) | +15.0% | +6.0% | +7.4% | +140 bps YoY | ~7% (midpoint) | ~+40 bps above guide |
EPS — Diluted Operating ($) | $2.72 | $2.78 | $2.85 | +2.5% YoY | $11.40–$11.60 (GAAP) | N/A (GAAP vs. Adj.) |
Segment Operating Margin (%) | ~14.0% | ~13.4% | ~14.4% | +100 bps YoY | Low 16% | ~−160 bps below guide |
Free Cash Flow ($B) | −$0.194B | $0.552B | $0.786B | +42% YoY | ~$3.0B | ~−74% below FY guide (back-half weighted) |
Book-to-Bill (x) | 1.29x | 1.50x | 1.11x (consensus) | −39 bps YoY | N/A (no formal guide) | N/A |
Sources: Visible Alpha Consensus and Actuals Data; L3Harris Q1 2026 Earnings Call (April 30, 2026). Segment operating margin consensus from VA EBIT margin — Operating(%). Free cash flow consensus from VA. Book-to-bill consensus from VA. Note: LHX transitioned to GAAP-only EPS reporting in 2026; operating EPS shown for comparability.
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $5.744B | $5.414B | +6.1% | Beat |
Q4 2025 | $5.648B | $5.773B | −2.2% | Miss |
Q3 2025 | $5.659B | $5.528B | +2.4% | Beat |
Q2 2025 | $5.426B | $5.309B | +2.2% | Beat |
Q1 2025 | $5.132B | $5.218B | −1.6% | Miss |
Q4 2024 | $5.523B | $5.496B | +0.5% | Beat |
Q3 2024 | $5.292B | $5.292B | 0.0% | In-Line |
Q2 2024 | $5.299B | $5.294B | +0.1% | In-Line |
Quarter | Reported | Consensus | Surprise (bps) | Result |
Q1 2026 | +15.0% | +7.3% | +775 bps | Massive Beat |
Q4 2025 | +5.7% | +7.8% | −210 bps | Miss |
Q3 2025 | +10.3% | +7.5% | +280 bps | Beat |
Q2 2025 | +6.0% | +2.4% | +360 bps | Beat |
Q1 2025 | −0.5% | −0.5% | 0 bps | In-Line |
Q4 2024 | +4.0% | +4.0% | 0 bps | In-Line |
Q3 2024 | +4.7% | +5.5% | −80 bps | Miss |
Q2 2024 | −0.1% | +3.0% | −310 bps | Miss |
Pattern: LHX has beaten revenue consensus in 5 of the last 8 quarters, with the magnitude of beats accelerating sharply — the Q1 2026 organic growth beat of +775 bps was the largest in the series. The two misses (Q4 2025 and Q2 2024) were both driven by timing/mix rather than demand weakness, and the trend since Q2 2025 has been consistent outperformance. This history supports a constructive setup for Q2 2026.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has been selectively raised since Q1 earnings — EPS guidance was lifted $0.10 on both ends while revenue guidance was held flat, a deliberate signal of conservatism from a new CFO 45 days into the job. Tone is unambiguously bullish on demand, with management framing the current environment as a “once-in-a-lifetime opportunity.”
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 30) | Revised Guidance | Current Consensus | Note |
FY 2026 Revenue | $23.0B – $23.5B (7% organic at midpoint) | — | $23.61B | Reaffirmed; CFO signaled conservatism; consensus sits at high end of range |
FY 2026 GAAP EPS | $11.40 – $11.60 (raised $0.10 on each end at Q1) | — | $11.59 | ↑ Raised at Q1 earnings; consensus near top of range; further raise likely if Q2 beats |
FY 2026 Segment Operating Margin | Low 16% | — | ~14.6% | Reaffirmed; consensus below guide — reflects mix shift toward lower-margin missile capacity build |
FY 2026 Free Cash Flow | ~$3.0B | — | $2.94B | Reaffirmed; back-half weighted; Q1 was −$194M; consensus slightly below guide |
Book-to-Bill (FY 2026) | No formal guide; Q1 actual 1.4x; international 2.2x | — | 1.11x (consensus) | No formal guidance; management commentary implies sustained above-1.0x; $25B MAC not yet in backlog |
Missile Solutions IPO (AXYV) | Confidential S-1 filed Apr 30; DoW $1B investment closed | JPMorgan & Morgan Stanley selected as lead underwriters (Jun 16); up to ~$2B raise; listing possible as soon as July | N/A | ↑ Progressing; IPO timeline is a key catalyst; guidance does not yet reflect IPO impact |
Sources: L3Harris Q1 2026 Earnings Call (April 30, 2026); Bloomberg / Perplexity (June 16, 2026 — AXYV IPO bank selection); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Estimates have moved modestly higher since the Q1 print — Q2 revenue consensus is up ~$43M (+0.7%) and operating EPS is essentially flat — suggesting the Street has not aggressively chased the Q1 beat. The gap between the 7% full-year organic growth guide and the 15% Q1 actual represents meaningful cushion if demand sustains, and any guidance raise on the Q2 call would be a positive catalyst.
KPI (Period) | Estimate (5 Days Post Q1 Earnings, ~May 5, 2026) | Current Consensus (Jul 28, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Revenue — Q2 2026 | $5.782B | $5.825B | +0.7% | No Q2-specific guide | No Q2-specific guide | N/A | N/A |
Revenue — FY 2026 | $23.619B | $23.606B | −0.1% | $23.0B–$23.5B | $23.0B–$23.5B (unchanged) | Unchanged | +0.5% above midpoint |
Organic Growth % — Q2 2026 | +7.3% | +7.4% | +10 bps | No Q2-specific guide | No Q2-specific guide | N/A | N/A |
Organic Growth % — FY 2026 | +9.1% | +8.8% | −30 bps | ~7% (midpoint) | ~7% (unchanged) | Unchanged | +180 bps above guide |
Operating EPS — Q2 2026 | $2.851 | $2.848 | −0.1% | No Q2-specific guide | No Q2-specific guide | N/A | N/A |
Operating EPS — FY 2026 | $11.851 | $11.846 | −0.0% | $11.40–$11.60 (GAAP) | $11.40–$11.60 (unchanged) | Unchanged | +2.1% above GAAP guide midpoint |
Free Cash Flow — FY 2026 | $3.023B | $2.940B | −2.7% | ~$3.0B | ~$3.0B (unchanged) | Unchanged | −2.0% below guide |
The most notable divergence is FY organic growth consensus (+8.8%) running nearly 180 bps above the company’s own 7% guide midpoint — the Street is already embedding some conservatism unwind. FCF estimates have drifted slightly lower post-Q1 (Q1 was −$194M), consistent with management’s back-half weighting commentary. A Q2 revenue beat would likely prompt both estimate upgrades and a guidance raise, which is the key re-rating catalyst.
Source: Visible Alpha Consensus and Actuals Data (as-of dates: May 5, 2026 and July 28, 2026); L3Harris Q1 2026 Earnings Call.
Key Takeaway: LHX has significantly underperformed the ITA Aerospace & Defense ETF since Q1 earnings (LHX −5% vs. ITA +12%), driven by the muted post-earnings reaction, the June 16 AXYV IPO bank selection news (which triggered a ~6% single-day decline on Iran deal / Hormuz reopening headlines), and a mid-July sector rotation. The late-July recovery (+8% from the July 21 trough) coincides with LMT and RTX Q2 beats and the PAC-3/THAAD framework announcements — suggesting sentiment is improving into the print.
LHX vs. ITA (iShares U.S. Aerospace & Defense ETF) — Indexed to 100 at Q1 2026 Earnings (Apr 30, 2026). Source: Stock Price Data.
Sector ETF: ITA (iShares U.S. Aerospace & Defense ETF) — appropriate for LHX’s defense electronics, missile systems, and communications sub-sectors. S&P 500 data not available in the pulled dataset; ITA is the primary benchmark.
Source: Stock Price Data (Yahoo Finance).
Key Takeaway: Peers reporting Q2 2026 results (LMT July 23, RTX July 23, NOC July 21) delivered uniformly strong beats with raised guidance, driven by the same demand tailwinds that benefit LHX — record missile/munitions bookings, accelerating international demand, and a $1.1T+ defense budget backdrop. The read-through is unambiguously positive for LHX’s missile, space, and communications segments.
Read-Through Relevance: HIGH — LMT’s Missiles & Fire Control (MFC) segment is the most direct read-through for LHX’s Missile Solutions segment (AXYV). LMT is also a partner on PAC-3 MSE propulsion (LHX supplies solid rocket motors).
Read-Through Relevance: HIGH — RTX’s Raytheon segment competes with and complements LHX in missile defense, tactical communications, and space. RTX’s demand commentary is the broadest read-through for the defense electronics market.
Read-Through Relevance: MEDIUM-HIGH — NOC competes with LHX in space (SDA tracking layer, national security space) and missile defense (IBCS, solid rocket motors). NOC’s space and missile commentary is directly relevant.
Read-Through Relevance: MEDIUM — DRS competes with LHX in tactical radars, space sensing (SDA Tranche 3), counter-UAS, and ISR. DRS’s Q1 commentary (about Q2 2026 outlook) is relevant as a forward-looking read-through.
Key Takeaway: The most important development since Q1 earnings is the July 27 PAC-3 MSE and THAAD framework agreements — the largest propulsion awards in LHX history — which directly validate the Missile Solutions (AXYV) growth thesis and provide multi-year revenue visibility heading into the IPO.
Sources: L3Harris press releases (July 27, July 13, 2026); L3Harris 8-K filings (July 24, May 12, 2026); Bloomberg / Perplexity (June 16, 2026); L3Harris Q1 2026 Earnings Call; LMT, RTX, NOC Q2 2026 Earnings Calls.
Key Takeaway: No open-market buys or discretionary sells by executives since Q1 earnings. All transactions are compensation-related awards (grants, RSU vesting, tax withholding) — nothing that signals bearish conviction. The July 24 Sustainment Awards (8-K) are a positive signal: $25M in performance-linked equity tied to organic revenue growth and segment margins through FY 2029 aligns management with long-term shareholder value creation.
Name | Title | Transaction Type | Amount / Shares | Date | Note |
Bedingfield, Kenneth L | President, Missile Solutions | Award (A) — Phantom Stock Units | 18.83 units | Jul 1, 2026 | Compensation grant; not a discretionary buy |
Geraghty, Joanna | Director | Award (A) — Common Stock | 149.71 shares | Jul 1, 2026 | Director compensation grant |
Regnery, David S | Director | Award (A) — Common Stock | 128.32 shares | Jul 1, 2026 | Director compensation grant |
Zamarro, Christina L | Director | Award (A) — Common Stock | 128.32 shares | Jul 1, 2026 | Director compensation grant |
Bailey, Sallie B (+ 8 other directors) | Director (x9) | Award (A) — Common Stock | 661 shares each | May 11, 2026 | Annual director equity compensation grants; routine |
Mehta, Samir | Pres., Space & Mission Systems | Award (A) — RSUs | 3,192 RSUs | May 1, 2026 | Compensation grant; not a discretionary buy |
Rakita, Melanie | VP & CHRO | 10b5-1 Planned Sale (S) + Tax Withholding (F) | 2,180 shares sold; 1,416 withheld | May 1–5, 2026 | 10b5-1 plan sale upon RSU vest; tax withholding; not discretionary |
Sharp, Kenneth P | SVP & CFO | Award (A) — RSUs + Stock Options | 2,593 RSUs; 10,021 options; 11,169 RSUs | May 1, 2026 | New CFO onboarding equity grants; not a discretionary buy |
Summary: All transactions in the period are compensation-related (grants, RSU vesting, 10b5-1 planned sales, tax withholding). There are no open-market discretionary buys or sells. The absence of insider selling is a mild positive signal. The July 24 Sustainment Awards — $25M in performance-linked equity for CFO Sharp, Missile Solutions President Bedingfield, and SMS/CSD President Mehta, tied to organic revenue growth and segment margins through FY 2029 — are the most meaningful insider signal: management is being incentivized to deliver on the long-term growth thesis.
Source: Insider Transaction Data (SEC Form 4 filings); L3Harris 8-K (July 24, 2026).